Shion An Lim (Susan Marqusee, Shion A Lim)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Angiotensin Converting Enzyme

Respiratory Syndrome Coronavirus

Binding Protein

Top Venues

Nature chemical biology

Proceedings of the National Academy of Sciences of the United States of America

Nature cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Avi J Samelson, Quang Dinh Tran, Rémy Robinot, Lucia Carrau, Veronica V Rezelj, Alice Mac Kain, Merissa Chen, Gokul N Ramadoss, Xiaoyan Guo, Shion An Lim, Irene Lui, James K Nuñez, Sarah J Rockwood, Jianhui Wang, Na Liu, Jared Carlson-Stevermer, Jennifer Oki, Travis Maures, Kevin Holden, Jonathan S Weissman, James A Wells, Bruce R Conklin, Benjamin R tenOever, Lisa A Chakrabarti, Marco Vignuzzi, Ruilin Tian, Martin Edward Kampmann
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. Nature cell biology 24 (1) (2022)
Colton J Bracken, Shion An Lim, Paige Solomon, Nicholas J Rettko, Duy P Nguyen, Beth Shoshana Zha, Kaitlin Schaefer, James R Byrnes, Jie Zhou, Irene Lui, Jia Liu, Katarina Pance, null null, Xin X Zhou, Kevin K Leung, James A Wells
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2. Nature chemical biology 17 (1) (2020)
Anum Azam Glasgow, Jeff E Glasgow, Daniel Limonta, Paige Solomon, Irene Lui, Sunny Zhang, Matthew A Nix, Nicholas J Rettko, Beth Shoshanna Zha, Rachel Yamin, Kevin Kao, Oren S Rosenberg, Jeffrey V Ravetch, Arun P Wiita, Kevin K Leung, Shion An Lim, Xin X Zhou, Tom C Hobman, Tanja Kortemme, James A Wells
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
James R Byrnes, Xin X Zhou, Irene Lui, Susanna K Elledge, Jeff E Glasgow, Shion An Lim, Rita P Loudermilk, Charles Y Chiu, Taia T Wang, Michael R Wilson, Kevin K Leung, James A Wells
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. mSphere 5 (5) (2020)
James R Byrnes, Xin X Zhou, Irene Lui, Susanna K Elledge, Jeff E Glasgow, Shion An Lim, Rita Loudermilk, Charles Y Chiu, Michael R Wilson, Kevin K Leung, James A Wells
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding. medRxiv : the preprint server for health sciences (2020)
Shion An Lim, Eric Richard Bolin, Susan Marqusee
Tracing a protein's folding pathway over evolutionary time using ancestral sequence reconstruction and hydrogen exchange. eLife 7 (2018)
Shion A Lim, Shion An Lim
The burst-phase folding intermediate of ribonuclease H changes conformation over evolutionary history. Biopolymers 109 (8) (2017)